JPMorgan Downgrades Lexicon Pharmaceuticals (LXRX) to Neutral
JPMorgan downgraded Lexicon Pharmaceuticals (NASDAQ: LXRX) from Overweight to Neutral ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)